Australia, Aug. 25 -- Bridgebio Pharma Inc., owns the trademark (2657219) for 'LYFIGLO' till April 29, 2036.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for the treatment and prevention of achondroplasia and hypochondroplasia.]
Type of Mark: Word
Date of Acceptance: June 17
Registration Advertised: Aug. 24
For further details contact Jessica L. Rothstein Goodwin Procter LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2657219.
Disclaimer: Curated by HT Syndication.
